7 slides from TECSYS's earnings presentation, Oct 3, 2024
Slide 1: Tecsys Q1 FY2025 Results Conference Call
Tecsys Q1 FY2025 Results Conference Call Peter Brereton, President and CEO Mark Bentler, Vice President and CFO A H I G H E R S TA N D A R D
Slide 2: Forward-looking statements
Forward-looking statements The statements in this presentation relating to matters that are not historical fact are forward looking statements that are based on management's beliefs and assumptions. Such statements are not guarantees of future performance, and are subject to a number of uncertaintie
Slide 3: Q1 FY25 highlights
Solid • Diversified bookings performance • Healthy fundamentals Q1 FY25 Market • White space penetration highlights access • Pharmacy momentum • Partner impact • Customer success Organizational strategy • New leadership • Company culture 3
Slide 4: Financial results highlights – Q1
Financial results highlights – Q1 in $CAD thousands, except EPS Q1 FY25 Q1 FY24 Change % Total Revenue 42,276 41,975 1% SaaS 15,314 11,495 33% Maintenance & Support 8,715 8,298 5% Professional Services 13,387 14,908 (10%) License 861 456 89% Hardware 3,999 6,818 (41%) Gross Profit 19,728 19,500 1% M
Slide 5: Financial guidance
Financial guidance Tecsys is reiterating previously presented financial guidance as follows: Reiterate Reiterate FY25 Guidance FY26 Guidance Total Revenue Growth 7-9% n.a. SaaS Revenue Growth 30-32% n.a. Adjusted EBITDA1 Margin 8-9% 10-11% 5 1 See Non-IFRS Performance Measures in Management’s Discus
Slide 6: Sustained shareholder value
Sustained shareholder value On track for continued market growth Market Strategic Customer opportunity approach success • Leverage footprint in healthcare • Easy to use and recommend • Prioritize customer satisfaction • Market growth channels • Stronger partner ecosystem • Value delivery • Widesprea
Slide 7: Thank you
*? tecsys” Thank you
Source: Internet Archive copy of infohub.tecsys.com